Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Barbara W. Kamholz, Suzy Bird Gulliver, Amy Helstrom & Sandra B. Morissette. (2009) Implications of Participant Self-Selection for Generalizability: Who Participates in Smoking Laboratory Research?. Substance Use & Misuse 44:3, pages 343-356.
Read now
Read now
J. Smit, K. Middelkoop, L. Myer, S. Seedat, R. Wood, D. J. Stein & L.-G Bekker. (2006) Sexual risk factors associated with volunteering for HIV vaccine research in South Africa. AIDS Care 18:6, pages 569-573.
Read now
Read now
Articles from other publishers (28)
Fabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, Manuel Feisst, Sabine Heublein, Thomas Maximilian Deutsch, Benedikt Schäfgen, Michael Golatta, Christoph Domschke, Markus Wallwiener, Jörg Heil & André Hennigs. (2021) Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017. The Breast 58, pages 63-71.
Crossref
Crossref
Matthew Gabel, Jonathan Gooblar, Catherine M. Roe & John C. Morris. (2021) The ideological divide in confidence in science and participation in medical research. Scientific Reports 11:1.
Crossref
Crossref
Pavan A. Vaswani, Thomas F. Tropea & Nabila Dahodwala. (2020) Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention. Neurotherapeutics 17:4, pages 1724-1735.
Crossref
Crossref
Lauren J. Beesley, Peter G. Hawkins, Lahin M. Amlani, Emily L. Bellile, Keith A. Casper, Steven B. Chinn, Avraham Eisbruch, Michelle L. Mierzwa, Matthew E. Spector, Gregory T. Wolf, Andrew G. Shuman & Jeremy M. G. Taylor. (2019) Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era. Cancer 125:1, pages 68-78.
Crossref
Crossref
Anam A. Ayaz-Shah, Samia Hussain & Simon R. Knight. (2018) Do clinical trials reflect reality? A systematic review of inclusion/exclusion criteria in trials of renal transplant immunosuppression. Transplant International 31:4, pages 353-360.
Crossref
Crossref
Marie Laurent, Laurent Brureau, Mounira El Demery, Aude Fléchon, Aurélie Le Thuaut, Muriel Carvahlo-Verlinde, Sylvie Bastuji-Garin, Elena Paillaud, Florence Canoui-Poitrine & Stéphane Culine. (2017) Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study. Urologic Oncology: Seminars and Original Investigations 35:1, pages 34.e9-34.e16.
Crossref
Crossref
Nandita Khera. (2015) From evidence to clinical practice in blood and marrow transplantation. Blood Reviews 29:6, pages 351-357.
Crossref
Crossref
Nandita Khera, Navneet S. Majhail, Ruta Brazauskas, Zhiwei Wang, Naya He, Mahmoud D. Aljurf, Görgün Akpek, Yoshiko Atsuta, Sara Beattie, Christopher N. Bredeson, Linda J. Burns, Jignesh D. Dalal, César O. Freytes, Vikas Gupta, Yoshihiro Inamoto, Hillard M. Lazarus, Charles F. LeMaistre, Amir Steinberg, David Szwajcer, John R. Wingard, Baldeep Wirk, William A. Wood, Steven Joffe, Theresa E. Hahn, Fausto R. Loberiza, Claudio Anasetti, Mary M. Horowitz & Stephanie J. Lee. (2015) Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial. Biology of Blood and Marrow Transplantation 21:10, pages 1815-1822.
Crossref
Crossref
Robert D. Vining, Stacie A. Salsbury & Katherine A. Pohlman. (2014) Eligibility determination for clinical trials: development of a case review process at a chiropractic research center. Trials 15:1.
Crossref
Crossref
James D Millard, Lawrence Muhangi, Moses Sewankambo, Juliet Ndibazza, Alison M Elliott & Emily L Webb. (2014) Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda. Trials 15:1.
Crossref
Crossref
Yun Hyung Koog, Hyungsun Wi & Won Young Jung. (2013) Eligibility criteria in knee osteoarthritis clinical trials: systematic review. Clinical Rheumatology 32:11, pages 1569-1574.
Crossref
Crossref
Rebecca M. Speck, Mary D. Sammel, John T. Farrar, Sean Hennessy, Jun J. Mao, Margaret G. Stineman & Angela DeMichele. (2013) Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer. Journal of Oncology Practice 9:5, pages e234-e240.
Crossref
Crossref
L. Schwentner, R. Van Ewijk, C. Kurzeder, I. Hoffmann, J. König, R. Kreienberg, M. Blettner & A. Wöckel. (2013) Participation in adjuvant clinical breast cancer trials: Does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients. European Journal of Cancer 49:3, pages 553-563.
Crossref
Crossref
P.R. Fitzsimmons, S. Blayney, S. Mina-Corkill & G.O. Scott. (2012) Older participants are frequently excluded from Parkinson's disease research. Parkinsonism & Related Disorders 18:5, pages 585-589.
Crossref
Crossref
Etienne Gayat, Matthieu Resche‐Rigon, Jean‐Yves Mary & Raphaël Porcher. (2012) Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study. Pharmaceutical Statistics 11:3, pages 222-229.
Crossref
Crossref
E. Gayat & R. Porcher. (2011) Comparaison de l’efficacité de deux thérapeutiques en l’absence de randomisation: intérêts et limites des méthodes utilisant les scores de propensionAdvantages and limitations of propensity score methods to analyze non-randomized clinical trials. Réanimation 21:1, pages 109-116.
Crossref
Crossref
Ganesh V. Raj, Saumil Karavadia, Bruce Schlomer, Yull Arriaga, Yair Lotan, Arthur Sagalowsky & Eugene Frenkel. (2010) Contemporary use of perioperative cisplatin‐based chemotherapy in patients with muscle‐invasive bladder cancer. Cancer 117:2, pages 276-282.
Crossref
Crossref
Etienne Gayat, Romain Pirracchio, Matthieu Resche-Rigon, Alexandre Mebazaa, Jean-Yves Mary & Raphaël Porcher. (2010) Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Medicine 36:12, pages 1993-2003.
Crossref
Crossref
Herbert I. Weisberg. 2010. Bias and Causation. Bias and Causation
321
339
.
Laurent Zini, Umberto Capitanio, Paul Perrotte, Claudio Jeldres, Shahrokh F. Shariat, Philippe Arjane, Hugues Widmer, Francesco Montorsi, Jean-Jacques Patard & Pierre I. Karakiewicz. (2009) Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma. Urology 73:2, pages 342-346.
Crossref
Crossref
Gunn Elisabeth Vist, Dianne Bryant, Lyndsay Somerville, Trevor Birminghem & Andrew D Oxman. (2008) Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database of Systematic Reviews 2010:1.
Crossref
Crossref
Jeffrey D. Greenberg, Mitsumasa Kishimoto, Vibeke Strand, Stanley B. Cohen, Thomas P. Olenginski, Thomas Harrington, Shelly P. Kafka, George Reed & Joel M. Kremer. (2008) Tumor Necrosis Factor Antagonist Responsiveness in a United States Rheumatoid Arthritis Cohort. The American Journal of Medicine 121:6, pages 532-538.
Crossref
Crossref
Ganesh V. Raj, Alexia Iasonos, Harry Herr & Sherri Machele Donat. (2006) Formulas Calculating Creatinine Clearance Are Inadequate for Determining Eligibility for Cisplatin-Based Chemotherapy in Bladder Cancer. Journal of Clinical Oncology 24:19, pages 3095-3100.
Crossref
Crossref
Monica Gandhi, Niloufar Ameli, Peter Bacchetti, Gerald B Sharp, Audrey L French, Mary Young, Stephen J Gange, Kathryn Anastos, Susan Holman, Alexandra Levine & Ruth M Greenblatt. (2005) Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS 19:16, pages 1885-1896.
Crossref
Crossref
P. Harter, A. du Bois, C. Schade-Brittinger, A. Burges, K. Wollschlaeger, M. Gropp, B. Schmalfeldt, J. Huober, A. Staehle & J. Pfisterer. (2005) Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Annals of Oncology 16:11, pages 1801-1805.
Crossref
Crossref
N. Hébert-Croteau, J. Brisson, J. Lemaire & J. Latreille. (2005) The benefit of participating to clinical research. Breast Cancer Research and Treatment 91:3, pages 279-281.
Crossref
Crossref
Lynn E Eberly, James D Neaton, Avis J Thomas & Yu Dai. (2016) Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial. Clinical Trials 1:2, pages 148-161.
Crossref
Crossref
Bruce Booth, Robert Glassman & Philip Ma. (2003) Oncology's trials. Nature Reviews Drug Discovery 2:8, pages 609-610.
Crossref
Crossref